Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in final guidance published today (15 January 2020).
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (17 July 2019).
NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.
Shared Learning Award 2019 finalist
NICE has today (28 August 2019) published its updated guideline on the diagnosis and treatment of high blood pressure (hypertension).
More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice
Women who have experience of, or are at risk of mental health problems, should get extra support before, during and after their pregnancy, says NICE.
Decisions around whether to offer a person surgical treatment should not be based on age and fitness, according to a new report.
NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.
More than half of people with diabetes are not having their cholesterol levels adequately controlled, according to a new study.
Ensuring people develop healthy habits from an early age can help prevent long-term disease and early death, says NICE.
A minimum price per unit of alcohol, as recommended by NICE, effectively targets high-risk drinkers while having little impact on moderate drinkers, according to a new study.
NICE is calling for people who are eligible for free flu vaccination to be offered it at every opportunity.
Senior health and social care leaders interested in becoming a NICE Fellow have just one week left to apply.
People with advanced breast cancer are set to benefit from a life-extending drug as NICE says it should be available on the NHS.
Approving regorafenib is a "welcome step forward" for those people who are eligible
Forthcoming NICE guidance will cover whether it is cost-effective to provide vitamin D supplements to all children under-five.
GPs should use either the FRAX or QFracture tools to estimate fracture risk in at-risk patients, NICE says.
NICE has issued new advice to help doctors quickly spot Lyme disease, so they can offer people NHS treatment as soon as possible.
NICE draft guidance recommends non-invasive prenatal testing (NIPT) for fetal rhesus-D status.
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
People who drink too much should be sent for scans to detect early liver disease, says NICE
The NHS is being urged to tackle the rise in antibiotic resistance by cutting back on unnecessary use of the drugs.
NICE has appointed Dr Rosie Benneyworth, a GP and former commissioner, as a new Non-Executive Director (NED) to its Board.
Uptake of NICE-approved medicines on the NHS to treat cardiovascular disease, diabetes and osteoporosis is higher than expected, latest figures reveal.
NICE is calling for women to be told that the coil is more effective than the ‘morning after pill’ for emergency contraception, in a new quality standard.
Healthcare professionals should consider a lower body mass index (BMI) when identifying the risk of weight-related conditions among people from black, Asian and minority ethnic groups, according to latest guidance from NICE.
Clinical Commissioning Groups (CCGs) cannot choose not to follow NICE guidance because they merely disagree with it, even where there is no statutory duty to do so, a court has ruled.
All young people in England should be given access to contraception and advice at convenient locations so no-one is denied services because of where they live, says NICE.
Bedside monitoring for hospital patients should be standardised and based on measures recommended by NICE, according to a new report.
Wider availability of low-cost supplements could help prevent health problems in millions of people at risk of vitamin D deficiency, NICE says.
Improving the health of local populations through encouraging more walking and cycling and by challenging unhealthy behaviours are among the aims of NICE?s latest set of local government public health briefings.
hree new indicators to improve dementia care could be added to the Quality and Outcomes Framework (QOF) incentive scheme for UK practices, as NICE unveils potential indicators for 2014/15.
Simple lifestyle changes, such as increased physical activity or eating more healthily, can prevent or delay type 2 diabetes, says NICE.
NICE?s new quality standard on caesarean section aims to ensure pregnant women can make an informed decision about their planned mode of birth.
NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.
The Prime Minister, David Cameron, has announced an extension to the Cancer Drugs Fund for two years. Since 2011, the fund has ring-fenced £200 million a year of the NHS budget for cancer treatments which may not yet have been assessed by NICE or which have been found not to be cost or clinically effective enough for wider use on the NHS. The Government?s extension will make the fund available until 2016.
GPs have a key role to play in the assessment and subsequent referral of patients with hepatitis B, according to experts.
A new device that detects the cause of unexplained vaginal wetness in pregnancy could help pregnant women avoid receiving unnecessary invasive speculum examinations, according to NICE.
NICE has approved the use of nalmefene to help people who are dependent on alcohol to cut down on the amount they drink.
If you have a story to share of an innovative or effective way you have put NICE guidance into practice, now is the time to submit it.
NICE’s first guideline on bladder cancer aims to improve the diagnosis and management of the seventh most common cancer in the UK.
NICE has launched a suite of guidelines to ensure that trauma services are delivered effectively and consistently.
Ensuring mothers are aware of the health benefits of breastfeeding, reducing the risk sudden of death syndrome, and assessing women for postnatal depression are among measures services can take to improve the quality of postnatal care, according to NICE.